Table: Fuso Pharmaceutical - 9-MTH parent results

Fuso Pharmaceutical Industries

13/02/2024 04:40

Feb 13 (Reuters)- 
             Fuso Pharmaceutical Industries Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2023        Dec 31, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             42.83               39.22            53.30    
                 (+9.2 pct)          (+2.5 pct)       (+4.5 pct)  
  Operating          1.84                1.97             2.00    
                 (-6.3 pct)          (+1.8 pct)       (-9.4 pct)  
  Recurring          1.83                2.06             2.00    
                 (-11.2 pct)         (+2.7 pct)       (-9.7 pct)  
  Net                1.23                1.49             1.30    
                 (-17.8 pct)         (-0.1 pct)       (-19.0 pct) 
  EPS            141.92 yen          170.30 yen       148.21 yen  
  Ann Div                             70.00 yen        70.00 yen  
  -Q2 div         35.00 yen           30.00 yen                   
  -Q4 div                             40.00 yen        35.00 yen  
  
  NOTE - Fuso Pharmaceutical Industries Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4538.T